[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Abbott Laboratories (ABT)

Abbott Laboratories (ABT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 151,485,472
  • Shares Outstanding, K 1,741,813
  • Annual Sales, $ 44,328 M
  • Annual Income, $ 6,524 M
  • EBIT $ 9,389 M
  • EBITDA $ 12,505 M
  • 60-Month Beta 0.63
  • Price/Sales 3.45
  • Price/Cash Flow 12.56
  • Price/Book 2.90

Options Overview Details

View History
  • Implied Volatility 35.13% (+0.81%)
  • Historical Volatility 24.81%
  • IV Percentile 100%
  • IV Rank 100.00%
  • IV High 35.13% on 06/03/26
  • IV Low 16.97% on 08/12/25
  • Expected Move (DTE 1) 1.70 (1.95%)
  • Put/Call Vol Ratio 0.64
  • Today's Volume 5,490
  • Volume Avg (30-Day) 21,611
  • Put/Call OI Ratio 0.68
  • Today's Open Interest 269,266
  • Open Int (30-Day) 247,278
  • Expected Range 85.29 to 88.69

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 28 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $1.28
  • Number of Estimates 7
  • High Estimate $1.28
  • Low Estimate $1.27
  • Prior Year $1.26
  • Growth Rate Est. (year over year) +1.59%

Price Performance

See More
Period Period Low Period High Performance
1-Month
81.97 +6.12%
on 05/11/26
89.72 -3.04%
on 05/04/26
-2.47 (-2.76%)
since 05/01/26
3-Month
81.97 +6.12%
on 05/11/26
113.95 -23.66%
on 03/04/26
-26.62 (-23.43%)
since 03/03/26
52-Week
81.97 +6.12%
on 05/11/26
139.06 -37.44%
on 06/24/25
-46.72 (-34.94%)
since 06/03/25

Most Recent Stories

More News
Is Abbott Laboratories Stock Underperforming the Dow?

Abbott Laboratories has trailed the Dow Jones Industrial Average over the past year, but analysts remain highly optimistic about the company's long-term growth prospects.

ABT : 86.99 (+0.02%)
BSX : 47.69 (+0.02%)
$DOWI : 50,687.07 (-1.21%)
3 Ultra-Reliable Dividend Kings Trading at Bargain-Basement Prices

These beaten-down Dividend Kings, trading near their 2026 lows, offer income, rebound potential, and Wall Street-backed upside for patient investors.

ABT : 86.99 (+0.02%)
LOW : 207.65 (+0.49%)
PEP : 142.54 (+0.38%)
Abbott secures CE Mark for world's first dual glucose-ketone sensing technology for people with diabetes

ABBOTT PARK, Ill. , May 27, 2026 /PRNewswire/ -- Abbott (NYSE: ABT), a global healthcare leader, announced today it has secured CE Mark for the world's first dual glucose‑ketone sensing technology...

ABT : 86.99 (+0.02%)
ACS guideline reaffirms Abbott leadership in noninvasive colorectal cancer screening

ABBOTT PARK, Ill. , May 27, 2026 /PRNewswire/ -- Abbott (NYSE: ABT) today announced that the American Cancer Society (ACS) has released updated colorectal cancer (CRC) screening guidelines that...

ABT : 86.99 (+0.02%)
Abbott showcases expanding evidence across its cancer diagnostics portfolio at ASCO 2026

ABBOTT PARK, Ill. , May 26, 2026 /PRNewswire/ -- Abbott (NYSE: ABT) will present 11 abstracts featuring new evidence across the cancer care continuum at the American Society of Clinical Oncology...

ABT : 86.99 (+0.02%)
Abbott Laboratories Stock Is Getting Decimated, But the Smart Money Senses Opportunity

While ABT stock appears poised to reach the year’s halfway mark in ignominy, the options market is quietly signaling a possible recovery.

ABT : 86.99 (+0.02%)
3 Dividend Aristocrats Under $100 to Buy and Hold Forever

These three Dividend Aristocrats under $100 offer steady payouts, reasonable payout ratios, and analyst-backed upside potential.

ABT : 86.99 (+0.02%)
MKC : 46.29 (+0.30%)
SJM : 101.27 (+0.80%)
MDT : 77.95 (+5.69%)
Insider Trades: Okta and Abbott See Buys, Micron Insiders Sell

See the recent insider activity surrounding Okta, Micron Technology, and Abbott Laboratories, and what these moves signal to investors.

ABT : 86.99 (+0.02%)
MU : 1,079.57 (+1.45%)
OKTA : 124.65 (-7.89%)
Sell in May and Go Away—Starting With These 3 Stocks

Oxford Club's Marc Lichtenfeld identifies three stocks worth selling in May—DexCom, Colgate-Palmolive, and Oracle—and breaks down the risks behind each call.

MSFT : 427.34 (-3.17%)
META : 622.98 (+4.24%)
GOOGL : 358.99 (-0.79%)
ABT : 86.99 (+0.02%)
CL : 84.87 (-3.85%)
ORCL : 230.33 (-5.83%)
DXCM : 72.77 (-0.93%)
BKH : 71.47 (-0.80%)
AMZN : 250.02 (-2.53%)
Abbott Laboratories Stock: Analyst Estimates & Ratings

While Abbott Laboratories has underperformed the broader market over the past year, Wall Street analysts maintain a bullish outlook on the stock’s prospects.

ABT : 86.99 (+0.02%)
XLV : 147.55 (+0.79%)
$SPX : 7,553.68 (-0.74%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Abbott Labs discovers, develops, manufactures & sells a diversified line of health care products. Established Pharmaceuticals Division includes branded generics business in the emerging markets. Medical Devices unit includes the diabetes care, vision care & vascular businesses. Diagnostics unit manufactures...

See More

Key Turning Points

3rd Resistance Point 89.22
2nd Resistance Point 88.66
1st Resistance Point 87.83
Last Price 86.99
1st Support Level 86.44
2nd Support Level 85.88
3rd Support Level 85.05

See More

52-Week High 139.06
Fibonacci 61.8% 117.25
Fibonacci 50% 110.51
Fibonacci 38.2% 103.78
Last Price 86.99
52-Week Low 81.97

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.